Artiva Biotherapeutics, Inc.

Contributing Author

Recent Articles by Artiva Biotherapeutics, Inc.

May-28	Artiva Biotherapeutics to Participate in the Jefferies Global Healthcare Conference ARTV GlobeNewswire
May-13	Artiva Biotherapeutics Announces Longer-term Phase 1/2 Data Demonstrating Prolonged Durability for AlloNK in Combination with Rituximab in Patients with B-cell-Non-Hodgkin Lymphoma at the ASGCT 28th Annual Meeting ARTV GlobeNewswire
May-08	Artiva Biotherapeutics Reports First Quarter 2025 Financial Results, Recent Business Highlights ARTV GlobeNewswire